Supporting the NHS with COVID-19 critical care information

Pharmaceutical Press from The Royal Pharmaceutical Society is today announcing the release of essential drug information focussed on supporting those working in critical care through the COVID-19 crisis. This is available to the NHS in England, Northern Ireland, Scotland and Wales, and to MedicinesComplete users at no charge.

Critical Illness is a new resource planned for publication next year, providing healthcare professionals working in intensive care units with specific guidance to help them make confident and effective decisions in this high-risk environment. Due to these exceptional circumstances, all available content is being released now. 

Pharmaceutical Press Managing Director, Karen Baxter said “I am incredibly grateful for the dedication and effort shown by the team at Pharmaceutical Press and our expert editors who have worked around the clock whilst also continuing their patient-facing roles to ensure we release this essential content set. We are glad to be able to support frontline NHS teams with this vital resource at such a pressured time.”

The advance release of Critical Illness, compiled by consultants and specialist pharmacists working in critical care comprises 6 monographs and prescribing guidance considered core for critical care units that follow dosing outside of standard regimens and are specifically useful for adult COVID-19 patients.

Dr Cathrine McKenzie, editor of Critical Illness and a clinical academic pharmacist with over 25 years’ experience in critical care said “I am really delighted to partner with my intensivist colleague’s Dr Barbara Philips and Dr Chris Kirwan and fellow pharmacist Greg Barton to provide, what we hope is a dynamic prescribing text to support critical care at this time of intense need. I also want to thank all the antimicrobial and intensive care pharmacists for their input into this early release and finally to Pharmaceutical Press for their support in transforming our ideas into a valuable resource.”

For more information about Critical Illness go to about.medicinescomplete.com/publication/critical-illness/

About MedicinesComplete

MedicinesComplete makes it easy for healthcare professionals to access essential medicines information at the point of care. Trusted evidence-based resources include British National Formulary, Stockley’s Drug Interactions, Martindale: The Complete Drug Reference, Palliative Care Formulary and many more specialist resources.

Our skilled editorial team of clinical writers includes pharmacists and science graduates who triage new information, assess evidence and review changes made by other clinical writers before publication. Certain content is further assessed by external experts, committee and peer review. Ensuring clear, concise and actionable guidance to support confident decision-making on the use and administration of drugs and medicines, and effective patient care.

As the Royal Pharmaceutical Society’s knowledge business, we invest all our resources into creating independent and unbiased knowledge to promote best practice in medicines use.

For more information email marketing@rpharms.com

About Pharmaceutical Press

When healthcare professionals need to make the right decision, Pharmaceutical Press puts evidence-based pharmaceutical knowledge at their fingertips. Trusted worldwide for providing accessible clinical advice that improves patient safety, with an unmatched commitment to independently sourcing, evaluating and communicating the most accurate information. As the Royal Pharmaceutical Society’s knowledge business, we invest all of our resources into creating world-class tools that promote best practice in medicines use, which means healthcare professionals can quickly and confidently make the most informed decisions.

MedicinesComplete is a Pharmaceutical Press product from The Royal Pharmaceutical Society.